These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 22126155)

  • 21. Interaction of hsa-miR-381 and glioma suppressor LRRC4 is involved in glioma growth.
    Tang H; Liu X; Wang Z; She X; Zeng X; Deng M; Liao Q; Guo X; Wang R; Li X; Zeng F; Wu M; Li G
    Brain Res; 2011 May; 1390():21-32. PubMed ID: 21435336
    [TBL] [Abstract][Full Text] [Related]  

  • 22. p53 enters the microRNA world.
    Hermeking H
    Cancer Cell; 2007 Nov; 12(5):414-8. PubMed ID: 17996645
    [TBL] [Abstract][Full Text] [Related]  

  • 23. DNA methylation of tumor-suppressor miRNA genes in chronic lymphocytic leukemia.
    Wang LQ; Chim CS
    Epigenomics; 2015; 7(3):461-73. PubMed ID: 25650645
    [TBL] [Abstract][Full Text] [Related]  

  • 24. MicroRNAs in human cancer: from research to therapy.
    Negrini M; Ferracin M; Sabbioni S; Croce CM
    J Cell Sci; 2007 Jun; 120(Pt 11):1833-40. PubMed ID: 17515481
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Transcriptional activation of miR-34a contributes to p53-mediated apoptosis.
    Raver-Shapira N; Marciano E; Meiri E; Spector Y; Rosenfeld N; Moskovits N; Bentwich Z; Oren M
    Mol Cell; 2007 Jun; 26(5):731-43. PubMed ID: 17540598
    [TBL] [Abstract][Full Text] [Related]  

  • 26. DNA methylation of microRNA genes in multiple myeloma.
    Wong KY; Huang X; Chim CS
    Carcinogenesis; 2012 Sep; 33(9):1629-38. PubMed ID: 22715154
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MicroRNA-34a functions as a potential tumor suppressor by inducing apoptosis in neuroblastoma cells.
    Welch C; Chen Y; Stallings RL
    Oncogene; 2007 Jul; 26(34):5017-22. PubMed ID: 17297439
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Analyses in human urothelial cells identify methylation of miR-152, miR-200b and miR-10a genes as candidate bladder cancer biomarkers.
    Köhler CU; Bryk O; Meier S; Lang K; Rozynek P; Brüning T; Käfferlein HU
    Biochem Biophys Res Commun; 2013 Aug; 438(1):48-53. PubMed ID: 23867826
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Methyl-CpG binding protein MBD2 is implicated in methylation-mediated suppression of miR-373 in hilar cholangiocarcinoma.
    Chen Y; Gao W; Luo J; Tian R; Sun H; Zou S
    Oncol Rep; 2011 Feb; 25(2):443-51. PubMed ID: 21165562
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MicroRNA-193a represses c-kit expression and functions as a methylation-silenced tumor suppressor in acute myeloid leukemia.
    Gao XN; Lin J; Li YH; Gao L; Wang XR; Wang W; Kang HY; Yan GT; Wang LL; Yu L
    Oncogene; 2011 Aug; 30(31):3416-28. PubMed ID: 21399664
    [TBL] [Abstract][Full Text] [Related]  

  • 31. OncomiRs: the discovery and progress of microRNAs in cancers.
    Cho WC
    Mol Cancer; 2007 Sep; 6():60. PubMed ID: 17894887
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Differential expression of microRNAs in human parathyroid carcinomas compared with normal parathyroid tissue.
    Corbetta S; Vaira V; Guarnieri V; Scillitani A; Eller-Vainicher C; Ferrero S; Vicentini L; Chiodini I; Bisceglia M; Beck-Peccoz P; Bosari S; Spada A
    Endocr Relat Cancer; 2010 Mar; 17(1):135-46. PubMed ID: 19926710
    [TBL] [Abstract][Full Text] [Related]  

  • 33. miR-181a and miR-630 regulate cisplatin-induced cancer cell death.
    Galluzzi L; Morselli E; Vitale I; Kepp O; Senovilla L; Criollo A; Servant N; Paccard C; Hupé P; Robert T; Ripoche H; Lazar V; Harel-Bellan A; Dessen P; Barillot E; Kroemer G
    Cancer Res; 2010 Mar; 70(5):1793-803. PubMed ID: 20145152
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Modulation of miRNA activity in human cancer: a new paradigm for cancer gene therapy?
    Tong AW; Nemunaitis J
    Cancer Gene Ther; 2008 Jun; 15(6):341-55. PubMed ID: 18369380
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MicroRNAs in cancer management and their modulation by dietary agents.
    Karius T; Schnekenburger M; Dicato M; Diederich M
    Biochem Pharmacol; 2012 Jun; 83(12):1591-601. PubMed ID: 22342289
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Developing technologies for epigenomic analysis and clinical application of molecular diagnosis].
    Yamamoto E; Suzuki H; Maruyama R; Shinomura Y
    Rinsho Byori; 2012 Jul; 60(7):637-43. PubMed ID: 22973723
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Genome-wide epigenetic regulation of miRNAs in cancer.
    Baer C; Claus R; Plass C
    Cancer Res; 2013 Jan; 73(2):473-7. PubMed ID: 23316035
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Epigenetic inactivation of mir-34b/c in addition to mir-34a and DAPK1 in chronic lymphocytic leukemia.
    Wang LQ; Kwong YL; Wong KF; Kho CS; Jin DY; Tse E; Rosèn A; Chim CS
    J Transl Med; 2014 Feb; 12():52. PubMed ID: 24559316
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Modeling miRNA regulation in cancer signaling systems: miR-34a regulation of the p53/Sirt1 signaling module.
    Lai X; Wolkenhauer O; Vera J
    Methods Mol Biol; 2012; 880():87-108. PubMed ID: 23361983
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The p53/miR-34 axis in development and disease.
    Rokavec M; Li H; Jiang L; Hermeking H
    J Mol Cell Biol; 2014 Jun; 6(3):214-30. PubMed ID: 24815299
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.